Onxeo Strengthens Beleodaq® Patent Protection in the U.S. Until 2027

Product News   Aug 29, 2014

 
Onxeo Strengthens Beleodaq® Patent Protection in the U.S. Until 2027
 
 
FURTHER INFORMATION
 

Related Product News

Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Next-Generation Sequencing

Product News

New product line leverages established DNA synthesis platform to revolutionize exome and custom sequencing.

READ MORE

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News

Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy.

READ MORE

Gilson Introduces Gilson Connect

Product News

Gilson announces launch of their cloud-connected platform powering new tools to help researchers achieve verifiable science. Tablet with microplate app and electronic pipette are first Internet of Things devices in the Gilson Connect Family.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE